a retrospective comparative study was performed on 54 patients treated medically or surgically (thymectomy) for myasthenia gravis (mg) from 1979- 1989 in three shiraz university hospitals. each surgical patient was compared with a medical patient on the basis of age, sex, severity and duration of disease. complete remission was noted in 3 out of 27 thymectomized patients but in none of the medi...

To determine the onset and recovery times and haemodynamic effects of intubating doses of atracurium (0.4 mg.kg-1), d-tubocurarine (0.8 mg.kg-1), pancuronium (0.12 mg.kg-1), and vecuronium (0.07 mg.kg-1), sixty-seven children aged one to eight years were studied under halothane and nitrous oxide anaesthesia. The time to maximum twitch depression and the time to recovery to T1/Tc 25 per cent wer...

PURPOSE To evaluate early and late histopathologic changes following posterior sub-Tenon injection of atracurium in the rabbit eye. METHODS This study was performed on 39 healthy white New Zealand rabbits which received sub-Tenon injection of 0.05-0.08 mg/kg atracurium diluted in 0.5 ml normal saline (N/S) in the left and 0.5 ml N/S in the right eyes. Bilateral enuclation was performed one ho...

BACKGROUND The Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite are two commonly used outcome measures in Myasthenia Gravis. So far, their measurement properties have not been compared, so we aimed to study their psychometric properties using the Rasch model. METHODS 251 patients with stable myasthenia gravis were assessed with both scales, and 211 patients returned fo...

BACKGROUND Clinical predictors for myasthenia gravis relapse and ocular myasthenia gravis secondary generalization during the first two years after disease onset remain incompletely identified. This study attempts to investigate the clinical predictors for the prognosis of Myasthenia Gravis. METHODS Eighty three patients with myasthenia gravis were concluded in this study. Baseline characteri...